MALAT1 and Miyoshi myopathy: As in other cancer types [15, 32], MALAT1 was found to interact with the methyltransferase EZH2 also in MM cells, and both MALAT1 and EZH2 inhibitors reduced H3K27Me3 at KEAP1 promoter, thus upregulating KEAP1 mRNA.